Urvi A. Shah, MD, MS, DipABLM is a lifestyle medicine certified hematologist, oncologist and physician scientist at Memorial Sloan Kettering Cancer Center. Her research interests in studying the role of modifiable risk factors (diet, metabolism, and microbiome) in cancer prevention, treatment, and survivorship with a focus on myeloma. She leads the NUTRIVENTION dietary intervention trials which is a series of 6 trials in patients with cancer and precancer states. Results from the first NUTRIVENTION trial have been published in Cancer Discovery. This is the first trial that showed that a high fiber diet improves key cancer risk markers and may delay progression to the cancer myeloma in patients with precursor plasma cell disorders. Dr. Shah has published first author papers in prominent journals such as Cancer Discovery, Blood, and Clinical Cancer Research amongst others and has been an invited speaker and session chair nationally and internationally.
Dr. Shah has been supported by career development awards (National Cancer Institute [NCI] K12, International Myeloma Society and American Society of Hematology [ASH] Scholar) and research awards (ECOG ACRIN Young Investigator Translational Research, Henry Moses, Celgene Future Leaders in Hematology, NCI Early Investigator Advancement Program, Clinical Cancer Research Early Career, ASH David M. Goldenberg CRTI, 40 under 40 in cancer). Her research has been funded by multiple foundations (Blood Cancer United, Gabrielle’s Angel, Allen, Riney, HealthTree, Society of MSK, Comedy vs Cancer and Willow Foundations).
Links mentioned in the podcast:
More Posts for Show: It’s All About Food